Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."

GREY:RPBIF - Post Discussion

Response Biomed Corp > more news same day
View:
Post by traderlong2 on Nov 07, 2012 7:39pm

more news same day

 

Response Biomedical to release Q3 results Nov. 14

2012-11-07 18:15 ET - News Release

 

Ms. Patricia Massitti reports

RESPONSE BIOMEDICAL CORPORATION SCHEDULES THIRD QUARTER 2012 EARNINGS RELEASE AND ANNOUNCES CONFERENCE CALL

Response Biomedical Corp. will release its financial results for the period ending Sept. 30, 2012, after markets close on Wednesday, Nov. 14, 2012.

Jeffrey L. Purvin, chief executive officer, will host a conference call on Wednesday, Nov. 14, 2012, at 2 p.m. PST (5 p.m. EST) to discuss the company's third quarter 2012 financial results. Also participating in the call will be Bill Adams, chief financial officer.

The conference call will be webcast live and is also available by dialling 1-877-644-1289 in North America or 1-914-495-8554 for all other locations. The conference ID is 43772173 and participants are encouraged to initiate their calls at least 10 minutes in advance of the 2 p.m. PST start time to ensure a timely connection.

The webcast and earnings release will be accessible at the Response Biomedical website, under events calendar, corporate. A replay of the conference call will also be available there approximately two hours after the call and for 90 days thereafter.

Comment by yoshka2000 on Nov 16, 2012 8:52pm
How many times has this stock been rolled back and each time the shareholders left holding the bag? So tell me, who should be walking on eggshells?